ABBV Stock Recent News

ABBV LATEST HEADLINES

ABBV Stock News Image - prnewswire.com

Select Business Owners Will Receive Access to Coaching, Mentorship, and Community During Exclusive 12-Week Virtual "Boostcamp" Additionally, 20 Entrepreneurs Will Each Receive a $20,000 Grant from BOTOX® Cosmetic IRVINE, Calif. , July 22, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: Empowering Women Entrepreneurs.

prnewswire.com 2025 Jul 22
ABBV Stock News Image - benzinga.com

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

benzinga.com 2025 Jul 21
ABBV Stock News Image - fool.com

It has been a volatile year for the U.S. markets, with many stocks experiencing impressive highs and sharp lows. Investing in such a turbulent environment may feel daunting for retail investors.

fool.com 2025 Jul 19
ABBV Stock News Image - seekingalpha.com

Dividend growth stocks can offer a stable way to passively grow one's income, creating long-term compounding wealth over the long run. Today, we are looking at a screening process that focuses on higher yields but ranks higher on dividend safety and consistency for growth. From the hundreds that end up listed, we take a look at some of those that rank on the higher yield end for an initial look.

seekingalpha.com 2025 Jul 18
ABBV Stock News Image - zacks.com

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

zacks.com 2025 Jul 18
ABBV Stock News Image - fxempire.com

AbbVie Inc. (ABBV) has emerged as a strong performer in financial and technical terms, attracting investor attention due to its long-term growth potential. With consistent revenue generation and expansion of its immunology and neuroscience portfolios, the company demonstrates operational strength.

fxempire.com 2025 Jul 18
ABBV Stock News Image - zacks.com

The latest trading day saw AbbVie (ABBV) settling at $190.58, representing a +2.25% change from its previous close.

zacks.com 2025 Jul 16
ABBV Stock News Image - zacks.com

ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.

zacks.com 2025 Jul 16
ABBV Stock News Image - zacks.com

ABBV hits a bullish golden cross as Skyrizi and Rinvoq drive growth, offsetting Humira losses and aesthetic headwinds.

zacks.com 2025 Jul 15
ABBV Stock News Image - 247wallst.com

There's really no such thing as a “no brainer” stock pick. I'd say that some opportunities are more compelling than others.

247wallst.com 2025 Jul 12
10 of 50